← FDA DRUG APPROVALS

FDA ANDA · ANDA087005

TRICHLORMETHIAZIDE

Sponsor: PAR PHARM

APPLICATION
ANDA087005
TYPE
ANDA
ORIGINAL APPROVAL
1981-02-06
LATEST ACTION
1994-01-28
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRICHLORMETHIAZIDEDiscontinued
TRICHLORMETHIAZIDE 4MG · TABLET · ORAL

Approval history

1994-01-28Manufacturing (CMC) · Supplement 16AP
1991-06-25Labeling · Supplement 17AP
1989-07-31Labeling · Supplement 15AP
1989-07-11Labeling · Supplement 14AP
1989-02-03Manufacturing (CMC) · Supplement 13AP
1986-08-14Manufacturing (CMC) · Supplement 8AP
1986-08-14Manufacturing (CMC) · Supplement 6AP
1983-06-07Manufacturing (CMC) · Supplement 3AP
1983-06-07Manufacturing (CMC) · Supplement 4AP
1983-06-07Manufacturing (CMC) · Supplement 2AP
1983-02-28Manufacturing (CMC) · Supplement 1AP
1981-02-06OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →